Michael Leuchten

Stock Analyst at UBS

(2.55)
# 2,210
Out of 4,876 analysts
9
Total ratings
71.43%
Success rate
9.72%
Average return
Main Sectors:

Stocks Rated by Michael Leuchten

Novo Nordisk
Jun 28, 2022
Downgrades: Sell
Price Target: n/a
Current: $68.51
Upside: -
AstraZeneca
Feb 25, 2021
Upgrades: Buy
Price Target: n/a
Current: $69.85
Upside: -
Sanofi
Jan 23, 2018
Downgrades: Underweight
Price Target: n/a
Current: $47.85
Upside: -